Instituto de Investigación, Innovación y Tecnología Educativas (UNIR iTED)
Facultad
Hospital Clinic Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (43)
2016
-
Infection-related and -unrelated malignancies, HIV and the aging population
HIV Medicine, Vol. 17, Núm. 8, pp. 590-600
-
MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: Relationship with antiviral immune response and disease progression
PLoS ONE, Vol. 11, Núm. 5
2015
-
Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study
HIV Medicine, Vol. 16, Núm. 9, pp. 533-543
-
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study
PLoS Medicine, Vol. 12, Núm. 3
2014
-
A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe
Infection, Vol. 42, Núm. 4, pp. 757-762
-
Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study
BMC Nephrology, Vol. 15, Núm. 1
-
HIV-2 and HTLV-1 infections in Spain, a non-endemic region
AIDS Reviews, Vol. 16, Núm. 3, pp. 152-159
-
Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in Europe
PLoS ONE, Vol. 9, Núm. 1
-
Incidence of Hepatitis C Virus (HCV) in a multicenter cohort of HIV-positive patients in Spain 2004-2011: Increasing rates of HCV diagnosis but not of HCV seroconversions
PLoS ONE, Vol. 9, Núm. 12
-
Tuberculosis in a cohort of HIV-positive patients: Epidemiology, clinical practice and treatment outcomes
International Journal of Tuberculosis and Lung Disease, Vol. 18, Núm. 6
2013
-
Hyaluronic Acid Levels Predict Risk of Hepatic Encephalopathy and Liver-Related Death in HIV/Viral Hepatitis Coinfected Patients
PLoS ONE, Vol. 8, Núm. 5
-
Resistance to the most recent protease and non-nucleoside reverse transcriptase inhibitors across HIV-1 non-B subtypes
Journal of Antimicrobial Chemotherapy, Vol. 68, Núm. 9, pp. 1994-2002
-
Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies
AIDS, Vol. 27, Núm. 1, pp. 81-85
2012
-
Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy
Retrovirology, Vol. 9
-
Hepatitis c virus viremia increases the Incidence of chronic kidney disease in HIV-infected Patients
AIDS, Vol. 26, Núm. 15, pp. 1917-1926
-
Prevalence of xenotropic murine leukemia virus-related virus infection in different risk populations in Spain
AIDS Research and Human Retroviruses, Vol. 28, Núm. 9, pp. 889-894
-
Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: The EuroSIDA study
PLoS ONE, Vol. 7, Núm. 7
-
Short communication: RNASEL alleles and susceptibility to infection by human retroviruses and hepatitis viruses
AIDS Research and Human Retroviruses, Vol. 28, Núm. 10, pp. 1259-1261
2011
-
A376s in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy
Journal of Infectious Diseases, Vol. 204, Núm. 5, pp. 741-752
-
Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patients
AIDS, Vol. 25, Núm. 6, pp. 761-766